chr6-33176171-C-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_080680.3(COL11A2):​c.2214+88G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.433 in 1,602,926 control chromosomes in the GnomAD database, including 155,517 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.47 ( 17233 hom., cov: 31)
Exomes 𝑓: 0.43 ( 138284 hom. )

Consequence

COL11A2
NM_080680.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.470

Publications

57 publications found
Variant links:
Genes affected
COL11A2 (HGNC:2187): (collagen type XI alpha 2 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]
COL11A2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 13
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • nonsyndromic genetic hearing loss
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive nonsyndromic hearing loss 53
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • otospondylomegaepiphyseal dysplasia
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 6-33176171-C-G is Benign according to our data. Variant chr6-33176171-C-G is described in ClinVar as Benign. ClinVar VariationId is 674768.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.727 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A2NM_080680.3 linkc.2214+88G>C intron_variant Intron 28 of 65 ENST00000341947.7 NP_542411.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A2ENST00000341947.7 linkc.2214+88G>C intron_variant Intron 28 of 65 5 NM_080680.3 ENSP00000339915.2
COL11A2ENST00000374708.8 linkc.1956+88G>C intron_variant Intron 26 of 63 5 ENSP00000363840.4
COL11A2ENST00000361917.6 linkc.786+88G>C intron_variant Intron 15 of 23 5 ENSP00000355123.2
COL11A2ENST00000477772.1 linkn.272+838G>C intron_variant Intron 5 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.469
AC:
71106
AN:
151726
Hom.:
17204
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.513
Gnomad AMI
AF:
0.213
Gnomad AMR
AF:
0.520
Gnomad ASJ
AF:
0.423
Gnomad EAS
AF:
0.746
Gnomad SAS
AF:
0.522
Gnomad FIN
AF:
0.505
Gnomad MID
AF:
0.452
Gnomad NFE
AF:
0.405
Gnomad OTH
AF:
0.472
GnomAD4 exome
AF:
0.429
AC:
623104
AN:
1451082
Hom.:
138284
Cov.:
32
AF XY:
0.431
AC XY:
311285
AN XY:
722512
show subpopulations
African (AFR)
AF:
0.499
AC:
16618
AN:
33282
American (AMR)
AF:
0.595
AC:
26478
AN:
44534
Ashkenazi Jewish (ASJ)
AF:
0.437
AC:
11399
AN:
26070
East Asian (EAS)
AF:
0.752
AC:
29790
AN:
39620
South Asian (SAS)
AF:
0.503
AC:
43285
AN:
86042
European-Finnish (FIN)
AF:
0.482
AC:
25244
AN:
52368
Middle Eastern (MID)
AF:
0.456
AC:
2618
AN:
5738
European-Non Finnish (NFE)
AF:
0.399
AC:
440683
AN:
1103360
Other (OTH)
AF:
0.449
AC:
26989
AN:
60068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
21199
42399
63598
84798
105997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13866
27732
41598
55464
69330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.469
AC:
71188
AN:
151844
Hom.:
17233
Cov.:
31
AF XY:
0.475
AC XY:
35287
AN XY:
74212
show subpopulations
African (AFR)
AF:
0.514
AC:
21243
AN:
41358
American (AMR)
AF:
0.520
AC:
7939
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.423
AC:
1466
AN:
3468
East Asian (EAS)
AF:
0.747
AC:
3851
AN:
5158
South Asian (SAS)
AF:
0.522
AC:
2518
AN:
4824
European-Finnish (FIN)
AF:
0.505
AC:
5313
AN:
10530
Middle Eastern (MID)
AF:
0.455
AC:
132
AN:
290
European-Non Finnish (NFE)
AF:
0.405
AC:
27528
AN:
67924
Other (OTH)
AF:
0.477
AC:
1005
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1889
3777
5666
7554
9443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.274
Hom.:
640
Bravo
AF:
0.477
Asia WGS
AF:
0.573
AC:
1990
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.2
DANN
Benign
0.62
PhyloP100
-0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2254287; hg19: chr6-33143948; COSMIC: COSV59495852; COSMIC: COSV59495852; API